COMPARATIVE IMMUNE MICROENVIRONMENT PROFILING IN HBV-, HCV-, AND DUAL-INFECTED HEPATOCELLULAR CARCINOMA: TOWARD ETIOLOGY-SPECIFIC IMMUNOTHERAPEUTIC TARGETS. FMHR. 2025;3(4):843-845. Accessed October 11, 2026. https://fmhr.net/index.php/fmhr/article/view/478